Oak Longevity vs BreezeMeds: Price and delivery differences
Oak Longevity vs BreezeMeds: Oak Longevity is the lower-cost option for compounded semaglutide and tirzepatide, while BreezeMeds highlights injectable and oral options with higher listed starting prices. Early verdict: choose Oak Longevity if low flat pricing and no subscription are your primary needs; choose BreezeMeds if you need injectable and oral product options displayed and want to confirm which price applies to which product.
Check Oak Longevity pricing and options
Key differences at a glance: Oak Longevity vs BreezeMeds
This comparison focuses on the most distinctive supported differences between Oak Longevity and BreezeMeds: pricing and price structure, product formats offered, subscription and billing terms, shipping and support features, and regulatory notes about compounded medications.
Pricing and price structure
Oak Longevity provides semaglutide starting at $133/month and tirzepatide starting at $199/month with an explicit one flat price for all dosages and no subscription required. BreezeMeds lists semaglutide injection starting at $199/month, tirzepatide injection starting at $299, and oral options displayed from $399, with a separate $169 figure shown without clear product association.
View Oak Longevity flat pricing details
Product formats and availability
Oak Longevity offers compounded semaglutide and compounded tirzepatide as its GLP-1 medications. BreezeMeds displays injectable semaglutide and tirzepatide plus oral semaglutide and oral tirzepatide as options on its intake landing page. The specific pricing tied to each BreezeMeds product requires confirmation, since the landing evidence shows multiple starting prices.
Subscription, billing, and refunds
Oak Longevity states billing is monthly on a non recurring basis with no subscription, and three month prescriptions are billed upfront; it also states no refunds are available after physician approval and once medication has shipped. BreezeMeds did not show clear billing commitments or refund terms in the captured evidence and advises confirming fees and renewal terms before enrollment.
Shipping, support, and clinical review
Oak Longevity includes free shipping with tracking and free health coaching, and notes same day approval is available for qualifying patients. Oak also specifies clinical review is asynchronous and board certified physicians in your state review every case; a video call and insurance are not required. BreezeMeds emphasizes discreet home delivery and ongoing support but the captured evidence advises users to confirm state availability and eligibility.
Regulatory notes and suitability
Both providers note that treatment is available only when a licensed clinician determines it is medically appropriate. Oak Longevity explicitly warns that compounded medications are not FDA approved finished products and are not reviewed by FDA for safety, effectiveness or quality. The BreezeMeds evidence states medication specific approval status must be confirmed and that branded and compounded products are not interchangeable.
Side by side: supported comparison table
| Criteria | Oak Longevity | BreezeMeds |
|---|---|---|
| Semaglutide starting price | $133/month (compounded) | $199/month (injection listed) |
| Tirzepatide starting price | $199/month (compounded) | $299/month (injection listed) |
| Oral GLP-1 options | Not shown | Oral semaglutide and oral tirzepatide displayed from $399 |
| Subscription model | No subscription, billed monthly non recurring; three month options billed upfront | Fees and renewal terms not fully visible; users should confirm |
| Shipping and support | Free shipping with tracking and free health coaching | Discreet home delivery and ongoing support |
| Regulatory note | Compounded medications are not FDA approved finished products | Approval status must be confirmed; compounding status not fully detailed |
How to choose based on supported differences
Price conscious shoppers with uncomplicated health histories who want a flat price and no subscription will find Oak Longevity supported by the evidence as the lower cost compounded option, with free coaching and shipping and asynchronous clinician review. If you need injectable and oral GLP-1 formats displayed and want to confirm which starting price applies to which product, BreezeMeds shows both injectable and oral options but asks users to confirm costs, eligibility, and state availability.
Start Oak Longevity enrollment
Choose Oak Longevity if…
You prioritize lower starting prices for compounded semaglutide ($133/mo) or tirzepatide ($199/mo), want a one price for all dosages with no subscription, value free shipping and free health coaching, and accept that compounded medications are not FDA approved finished products and that treatment is subject to clinician review.
Choose BreezeMeds if…
You need to see injectable and oral GLP-1 options listed and are prepared to confirm the specific pricing, eligibility, renewal terms, and state availability before enrolling. The captured evidence shows BreezeMeds displays injectables and oral options starting at higher listed prices and advises confirmation of product specific details.
Primary keyword: Oak Longevity vs BreezeMeds
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →